Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 13.45 Billion | USD 26.23 Billion | 7.7% | 2023 |
According to Zion Market Research, the global Implantable drug delivery devices Market was worth USD 13.45 Billion in 2023. The market is forecast to reach USD 26.23 Billion by 2032, growing at a compound annual growth rate (CAGR) of 7.7% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Implantable drug delivery devices Market industry over the next decade.
With the help of implantable drug delivery devices, it has become possible to have site-specific drug delivery. This is of great importance in cardiology and oncology. Implantable drug delivery devices help in the constant release of a therapeutic agent. Implantable drug delivery devices require smaller dosages as compared to its counterpart, which in turn reduces the probability of side effects from drugs. Implantable drug delivery devices are used in a number of applications including HIV/AIDS prevention, diabetes management, chronic pain management, central nervous system (CNS) health, oncology, contraception, and cardiology.
However, the global markets are slowly opening to their full potential and there's a surge in demand. The market would remain bullish in upcoming year. The significant decrease in the global Implantable drug delivery devices market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.
Global implantable drug delivery devices market is primarily driven by growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases. Other major driving factors for growth of implantable drug delivery devices market is rising cases of unwanted pregnancies. However, strict government regulations implied on this industry and the high cost of these devices are major restraints that may curb the growth of the market. Nonetheless, the introduction of new and more effective implantable drug delivery devices is likely to disclose the new avenues for implantable drug delivery devices market in the near future.
The implantable drug delivery devices market is segmented on the basis of different products including drug infusion pumps, drug delivery devices, bio-absorbable stents, coronary drug eluting stents, brachytherapy seeds, contraceptive drug delivery implants and others. In 2020, implantable drugs infusion pumps were the largest segment of implantable drug delivery devices market and accounted for the largest share of the total market. Additionally, it is expected to continue its dominance and be the fastest growing segment in the global market over the forecast period. Contraceptive drug delivery device is another major product segment of implantable drug delivery devices.
Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others are the key end-user segment of the global implantable drug delivery devices market. The cardiovascular end-user segment dominated the market in terms of revenue. The cardiovascular segment is likely to have a significant growth within the forecast period and is projected as the fastest growing segment as a result of increasing usage of bio-absorbable stents.
Report Attributes | Report Details |
---|---|
Report Name | Implantable drug delivery devices Market |
Market Size in 2023 | USD 13.45 Billion |
Market Forecast in 2032 | USD 26.23 Billion |
Growth Rate | CAGR of 7.7% |
Number of Pages | 145 |
Key Companies Covered | Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others. |
Segments Covered | By Products, By End-users and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global implantable drug delivery devices market. North America is expected to remain the dominant region over the forecast period. Europe was a second-largest market for implantable drug delivery devices in 2020. Asia Pacific is expected to be the fastest growing region in implantable drug delivery devices market during the forecast period. Moreover, Latin America is also expected to show noticeable growth for this market in the years to come.
Some of the major players of the global implantable drug delivery devices market include
By Products
By End-users
By Region
FrequentlyAsked Questions
According to Zion Market Research, the global Implantable drug delivery devices Market was worth USD 13.45 Billion in 2023. The market is forecast to reach USD 26.23 Billion by 2032.
According to Zion Market Research, the global Implantable drug delivery devices Market a compound annual growth rate (CAGR) of 7.7% during the forecast period 2024-2032.
Some of the key factors driving the global Implantable drug delivery devices Market growth is growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases.
North America is expected to remain the dominant region over the forecast period. Europe was a second largest market for implantable drug delivery devices in 2023.
Some of the major players of global Implantable drug delivery devices market Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed